Apieron develops a Breath Test To Diagnose Asthma
Apieron, a medical devices company, has developed a novel diagnostic breath test for Asthma that is simple and highly accurate. The company’s device measures a […]
Articles by Herina Ayot
Pronucleotein Biotechnologies identifies Bacteria Via a Handheld Device
Pronucleotein Biotechnologies develops short DNA (nucleotide) or protein sequences that recognize bacteria or other targets, such as toxins. These short sequences (aptamers) are attached to […]
Provista Diagnostics
Provista Diagnostics, Inc., a Delaware company, is a privately held molecular diagnostics company offering diagnostic testing and reference clinical laboratory services tot he pharmaceutical and […]
The Neurology Market: A Glance (video)
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain.
Akonni Biosystems Inks Agreement with Lead Medical Research Laboratory
Akonni Biosystems, a molecular diagnostics company that develops rapid, low-cost and highly scalable solutions for infectious disease testing has signed a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases.
EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
Health 2.0 Spring Fling 2011
Health 2.0 announces its Spring Fling for 2011. Following trips to Boston and Paris in their two previous Spring Conferences, they are returning to the […]
ECI Biotech Can Sense Infection
An innovative approach to wound care, ECI Biotech makes simple and affordable sensors, branded, ExpressDetect, that turn blue in the presence of harmful microbial pathogens.
Breakthrough Study Indicates CNS Response’s Referenced-EEG Enables Physicians to Significantly Improve Success Rates in Treating Depression
According to The Journal of Psychiatric Research, a breakthrough study by CNS Response, Inc. (OTCBB: CNSO), reveals that physicians using CNS’s Referenced-EEG® (rEEG), an online reference database, were able to significantly improve their success in treating patients with depression, including patients with treatment-resistant depression.
The Executive Council Hosts a Forum to Discuss The Hospital Crisis in NYC
The Executive Council brought together experts in the healthcare industry over an intimate breakfast at The Harvard Club Tuesday, February 22, 2011.